Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy from a clinician's perspective

F D Goebel1

  • 1Ludwig-Maximilians-Universität, Munich, Germany.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.

Gene therapy·2010
Same author

Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.

European journal of medical research·2007
Same author

Clinical news from the XVI International AIDS Conference: The attempt of a summing up.

Infection·2006
Same author

Severe hepatotoxicity associated with the combination of enfuvirtide and tipranavir/ritonavir: case report.

AIDS (London, England)·2006
Same author

Treatment interruption in HIV therapy: a SMART strategy?

Infection·2006
Same author

Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edge.

Infection·2006
Same journal

Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination of treatments?

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Mortality risk in selenium-deficient HIV-positive children.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Predictors and risk-taking consequences of drug use among HIV-infected women.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Correlates of condom failure in a sexually active cohort of men who have sex with men.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
Same journal

Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1999
See all related articles

Combination antiretroviral therapy shows promise for HIV treatment, but optimal timing and regimen selection remain key unanswered questions. Addressing global access, patient adherence, and monitoring tools is crucial for effective HIV management.

Area of Science:

  • Infectious Diseases
  • Virology
  • Clinical Pharmacology

Background:

  • Significant advancements have been made in understanding HIV pathogenesis and the efficacy of combination antiretroviral therapies (ART).
  • However, critical questions persist regarding the optimal timing and specific drug regimens for initiating ART.
  • A notable gap exists between in vitro/clinical trial findings and real-world clinical application of ART.

Purpose of the Study:

  • To review the current landscape of combination antiretroviral therapy for HIV.
  • To identify key challenges and considerations for translating clinical trial successes into effective clinical practice.
  • To highlight areas requiring further research and development for optimal HIV management.

Main Methods:

  • Review of existing scientific literature and clinical trial data on combination ART.

Related Experiment Videos

  • Analysis of factors influencing the clinical application of ART, including drug availability, patient adherence, and CNS disease prevention.
  • Discussion of requirements for monitoring ART efficacy and addressing cost-related barriers.

    • Main Results:

    • Antiretroviral agent availability and approved indications vary significantly worldwide, often necessitating suboptimal regimens.
    • Patient adherence to complex, long-term combination ART regimens is a critical factor influencing treatment success.
    • Zidovudine (AZT) demonstrates efficacy in preventing HIV-associated CNS disease, suggesting its potential inclusion in combination regimens.

    Conclusions:

    • Effective translation of combination ART from trials to clinics requires addressing global drug access, patient adherence, and CNS disease prevention strategies.
    • Development and worldwide regulatory approval of accessible viral load monitoring tools are essential for assessing ART efficacy.
    • Addressing the increased cost of HIV management with combination ART is vital for widespread acceptance and implementation.